Trials / Terminated
TerminatedNCT01001793
Levacor™ Ventricular Assist Device (VAD) Bridge to Transplant Study
Evaluation of the Levacor™ Ventricular Assist Device as a Bridge to Cardiac Transplantation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- World Heart Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Levacor™ Ventricular Assist Device (VAD) has been designed for mechanical circulatory support in heart failure patients. The purpose of this clinical study is to determine its safety and efficacy as a bridge to transplant (BTT) in cardiac transplant candidates with presumed non-reversible left ventricular failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Levacor Ventricular Assist Device | Surgical procedure |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2009-10-27
- Last updated
- 2011-12-23
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01001793. Inclusion in this directory is not an endorsement.